CLEC7A and neoplasm: For example, tumor-associated DCs are also activated by Dectin-1, which simultaneously blocks Th2 cells and induces CD103+CD8+ mucosal T-cell differentiation to eliminate pre-existing breast cancers (Figure 3B; Wu et al., 2014).